Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products

RTTNews | 728日前
Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products

(RTTNews) - Brazilian agricultural biologicals company Agrivalle announced Friday a new partnership with Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity.

Together, the companies will collaborate on building cutting edge technologies to advance Agrivalle's biological products, including next-gen fertilizers and biocontrol agents.

Ginkgo is bringing its suite of advanced biology tools to the partnership with Agrivalle. Ginkgo will leverage its Strain Optimization Services to improve the efficacy of Agrivalle's biocontrol products.

In planned future projects, Ginkgo intends to work with Agrivalle to discover and optimize plant-compatible microbes that can provide crop nutrition, and to engineer organisms that can make compounds to specifically target certain pests.

read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | 603日前
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews | 695日前
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | 1229日前
Swiss Market Settles Modestly Higher

Swiss Market Settles Modestly Higher

The Switzerland market shrugged off a sluggish start and stayed fairly steady right till the end of the session on Friday to finish modestly higher.
RTTNews | 6時6分前
Major European Markets Close On Mixed Note

Major European Markets Close On Mixed Note

Despite a fairly good spell in positive territory till noon, European stocks failed to sustain at higher levels and ended on a mixed note on Friday. Investors digested the economic data from the region as well from the U.S., and looked ahead to next week's monetary policy announcement from the Federal Reserve.
RTTNews | 6時39分前